InvestorsHub Logo

Kentucky123

10/13/17 7:06 PM

#124564 RE: falconer66a #124553

I always enjoy your take on what is happening with the science of AVXL. You have a good grasp of how the drug works and insight that I do not have.
Stock price and valuation is something I have over 60 years experience. This stock will move when the big boys want it to and not before. It will come out of the blue with little or no warning and on no news. The stock has been under distribution for about the last 4 months with a downward bias. When will it change? Who knows. It is a good story that if true will be of great benefit to mankind.

Rubyred77

10/13/17 7:10 PM

#124565 RE: falconer66a #124553

Whats intriguing is how Australia will treat Anavex. They see their citizens in the trial. What does it take for Australia to approve or better question is would they approve before the FDA does.

Turner2017

10/13/17 7:34 PM

#124567 RE: falconer66a #124553

I agree with you, Anavex does not get any respect from the general market. Yesterday's share price action was very disappointing. The news was deemed excellent and we only gained 8%. Unless further good news keeps coming out, the share price will continue to slightly dwindle, which has basically been the case since the stock was trading in the 6's.

The street doesn't know and/or care about Anavex, I think that will change when we release good results from the Rett Trial meaning eventual FDA approval or data from the Alz trial before that.